Ranbaxy Laboratories reports net loss of Rs 925.66 crore in Q2

09 Aug 2012 Evaluate

Ranbaxy Laboratories has reported results for second quarter ended June 30, 2012.

On standalone basis, the company has reported a net loss of Rs 925.66 crore for the quarter ended June 30, 2012 against net profit of Rs 150.37 crore for the corresponding period last fiscal.  However, total income increased by 22.23% at Rs 1586.98 crore during the quarter under review from Rs 1298.34 crore in the year-ago period.

On Consolidated basis, the company has reported a net loss of Rs 585.72 crore for the quarter ended June 30, 2012 against net profit of Rs 243.23 crore for the corresponding period last fiscal. However, total income increased by 54.82% at Rs 3298.21 crore during the quarter under review from Rs 2130.31 crore in the year-ago period.

Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×